RaySearch acquires the product DrugLog from Pharmacolog for chemotherapy quality assurance
RaySearch (publ) announces today the acquisition of the product DrugLog™ ️ from Pharmacolog AB. DrugLog is a cost-effective solution for verifying the identity and concentration of compounded injectable medications, used for cancer treatment with cytostatic drugs (chemotherapy).Through this agreement, RaySearch acquires full ownership of all rights to the product DrugLog for its application in the field of oncology, including the measuring device, calibration parameters, source code, as well as intellectual property rights. The purchase price for the asset acquisition amounts to SEK 7